Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes

NCT00038870 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00038870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00038870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes
Lead sponsor
M.D. Anderson Cancer Center
Phase
Not applicable
Overall status
Withdrawn
Start date
January 31, 2001
Completion date
January 14, 2003
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute myelogenous leukemia, chronic myelogenous leukemia